Response to letter regarding article "Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease"

Letter/Communication

Matthew R Weir, Veronica Ashton, Kenneth T Moore, Shubham Shrivastava, Eric D Peterson and Eric M Ammann

The American heart journal, Vol.223, pp.111-112

05/2020

DOI: 10.1016/j.ahj.2020.03.002

PMID: 32386598

View Online

Title: Subtitle: Response to letter regarding article "Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease"
Creators: Matthew R Weir - University of Maryland, Baltimore
Veronica Ashton
Kenneth T Moore - Janssen Medical Affairs, Titusville, NJ
Shubham Shrivastava
Eric D Peterson - Duke University
Eric M Ammann
Resource Type: Letter/Communication
Publication Details: The American heart journal, Vol.223, pp.111-112
DOI: 10.1016/j.ahj.2020.03.002
PMID: 32386598
ISSN: 0002-8703
eISSN: 1097-6744
Language: English
Date published: 05/2020
Academic Unit: Epidemiology
Record Identifier: 9984363640402771

4 Record Views